We are live on ! Find out more
OM icon

Outset Medical

152 hedge funds and large institutions have $2.33B invested in Outset Medical in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 43 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

254% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $2.86M

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

49% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 43

4% more capital invested

Capital invested by funds: $2.24B → $2.33B (+$91M)

0.34% more ownership

Funds ownership: 6.88%7.21% (+0.34%)

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

3% less funds holding

Funds holding: 156152 (-4)

Holders
152
Holders Change
-4
Holders Change %
-2.56%
% of All Funds
2.4%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
20
Increased
64
Reduced
43
Closed
22
Calls
$10.1M
Puts
$2.86M
Net Calls
+$7.26M
Net Calls Change
+$772K
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
76
Cubist Systematic Strategies
Connecticut
$1.1M +$596K +990 +158%
AIG
77
American International Group
New York
$1.06M -$65.6K -109 -7%
Stifel Financial
78
Stifel Financial
Missouri
$1.05M -$93.9K -156 -9%
EGM
79
Engineers Gate Manager
New York
$1.02M +$906K +1,506 New
LBA
80
Letko, Brosseau & Associates
Quebec, Canada
$1.02M
Man Group
81
Man Group
United Kingdom
$1.01M +$280K +466 +46%
Rockefeller Capital Management
82
Rockefeller Capital Management
New York
$999K -$3.61K -6 -0.4%
Holocene Advisors
83
Holocene Advisors
New York
$887K +$783K +1,302 New
VOYA Investment Management
84
VOYA Investment Management
Georgia
$836K +$16.2K +27 +2%
Legal & General Group
85
Legal & General Group
United Kingdom
$782K +$14.4K +24 +2%
DekaBank Deutsche Girozentrale
86
DekaBank Deutsche Girozentrale
Germany
$773K -$99.9K -166 -12%
PPA
87
Parametric Portfolio Associates
Washington
$772K -$39.7K -66 -6%
BCI
88
Brinker Capital Investments
Pennsylvania
$740K -$125K -207 -16%
CC
89
Cannell & Co
New York
$725K
Envestnet Asset Management
90
Envestnet Asset Management
Illinois
$706K +$44.5K +74 +8%
DFCM
91
Dark Forest Capital Management
Puerto Rico
$634K +$560K +931 New
Principal Financial Group
92
Principal Financial Group
Iowa
$624K +$9.63K +16 +2%
DT
93
Diversified Trust
Tennessee
$541K +$95.1K +158 +25%
ASRS
94
Arizona State Retirement System
Arizona
$491K +$9.03K +15 +2%
State Board of Administration of Florida Retirement System
95
State Board of Administration of Florida Retirement System
Florida
$462K
BP
96
BBR Partners
New York
$443K
OAM
97
Oppenheimer Asset Management
New York
$441K +$65.6K +109 +20%
Handelsbanken Fonder
98
Handelsbanken Fonder
Sweden
$418K -$92.7K -154 -20%
ProShare Advisors
99
ProShare Advisors
Maryland
$398K -$57.2K -95 -14%
CGH
100
Crossmark Global Holdings
Texas
$394K +$160K +266 +85%

OM Hedge Fund Activity: Q1 2022 in Review

152 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2022, worth a combined $2.33B — up 4.1% from $2.24B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of OM and 20 opened new positions — a net loss of 2 holders — while 43 trimmed existing stakes and 64 added.

The largest buyer was Bellevue Group, adding an estimated $58.4M. The largest seller was BlackRock, cutting an estimated $16.6M.

  • 152 institutional investors held Outset Medical (OM) as of Q1 2022, down from 156 in Q4 2021.
  • Funds reported $2.33B of Outset Medical stock for Q1 2022, up 4.1% quarter-over-quarter.
  • 20 funds opened new Outset Medical positions in Q1 2022 and 22 closed out, a net change of -2 holders.
  • The largest Outset Medical buyer in Q1 2022 was Bellevue Group, an estimated $58.4M added.
  • The largest Outset Medical seller in Q1 2022 was BlackRock, an estimated $16.6M sold.

Based on aggregated 13F filings for Q1 2022.